Patient’s Choice Act of 2024

The Patient’s Choice Act of 2024 prohibits federal agencies from implementing or enforcing a 2023 proposed rule that would have shortened the maximum duration of short-term health insurance plans. It blocks efforts to reduce the current allowable term for these plans below the existing standard, ensuring they can still be offered with an initial term under 12 months and a total duration of up to 3 years (including renewals). This bill directly affects health insurance issuers and consumers who rely on short-term plans as a temporary coverage option. The legislation maintains the current regulatory framework without altering plan requirements or creating new benefits.